XML 48 R39.htm IDEA: XBRL DOCUMENT
v3.22.2

Segment and Geographic Information (Tables) | 9 Months Ended
--- | ---
Jun. 30, 2022
Segment Reporting [Abstract] |
Financial Information for Business Segments | The following is the summary of the financial information for the Company’s reportable segments for the three and nine months ended June 30, 2022 and 2021 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended June 30, | ​ | ​ | Nine Months Ended June 30, | ​
​ | ​ | ​ | 2022 | ​ | 2021 | ​ | 2022 | ​ | 2021 | ​
Revenue: |  | ​ | ​ | ​ | ​ | ​ |  |  | ​ |  |  | ​ |  | ​
Life Sciences Products | ​ | ​ | $ | 47,369 | ​ | $ | 48,625 | ​ | $ | 150,861 | ​ | $ | 146,520 | ​
Life Sciences Services | ​ | ​ |  | 85,366 | ​ |  | 80,462 | ​ |  | 267,070 | ​ |  | 230,244 | ​
Total revenue | ​ | ​ | $ | 132,735 | ​ | $ | 129,087 | ​ | $ | 417,931 | ​ | $ | 376,764 | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating loss: | ​ | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Life Sciences Products | ​ | ​ | $ | 2,216 | ​ | $ | 5,060 | ​ | $ | 11,895 | ​ | $ | 16,492 | ​
Life Sciences Services | ​ | ​ |  | 2,251 | ​ |  | 5,774 | ​ |  | 14,997 | ​ |  | 18,316 | ​
Reportable segment adjusted operating income | ​ | ​ | ​ | 4,467 | ​ | ​ | 10,834 | ​ | ​ | 26,892 | ​ | ​ | 34,808 | ​
Amortization of completed technology | ​ | ​ | ​ | 1,810 | ​ | ​ | 2,173 | ​ | ​ | 5,424 | ​ | ​ | 6,200 | ​
Amortization of other intangible assets | ​ | ​ | ​ | 5,745 | ​ | ​ | 7,396 | ​ | ​ | 18,064 | ​ | ​ | 21,657 | ​
Restructuring charges | ​ | ​ | ​ | 25 | ​ | ​ | — | ​ | ​ | 319 | ​ | ​ | 53 | ​
Tariff adjustment | ​ | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (486) | ​ | ​ | 5,414 | ​
Other unallocated corporate expenses | ​ | ​ | ​ | 1,960 | ​ | ​ | 2,148 | ​ | ​ | 13,677 | ​ | ​ | 11,331 | ​
Total operating loss | ​ | ​ | ​ | (5,073) | ​ | ​ | (883) | ​ | ​ | (10,106) | ​ | ​ | (9,847) | ​
Interest income | ​ | ​ | ​ | 6,822 | ​ | ​ | 409 | ​ | ​ | 9,933 | ​ | ​ | 503 | ​
Interest expense | ​ | ​ | ​ | (2,101) | ​ | ​ | (477) | ​ | ​ | (4,111) | ​ | ​ | (1,485) | ​
Loss on extinguishment of debt | ​ | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (632) | ​ | ​ | — | ​
Other income (expenses), net | ​ | ​ | ​ | 630 | ​ | ​ | (1,651) | ​ | ​ | (1,617) | ​ | ​ | (263) | ​
Income (loss) before income taxes | ​ | ​ | $ | 278 | ​ | $ | (2,602) | ​ | $ | (6,533) | ​ | $ | (11,092) | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Assets: | ​ | ​ | ​ | Life Sciences Products | ​ | ​ | Life Sciences Services | ​ | ​ | Total | ​ | ​ | ​ | ​
June 30, 2022 | ​ | ​ | $ | 319,632 | ​ | $ | 876,589 | ​ | $ | 1,196,221 | ​ | ​ | ​ | ​
September 30, 2021 | ​ | ​ |  | 278,769 | ​ | ​ | 780,238 | ​ |  | 1,059,007 | ​ | ​ | ​ | ​
​
Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, |  | September 30,
​ | ​ | 2022 | ​ | 2021
Segment assets |  | $ | 1,196,221 |  | $ | 1,059,007
Cash and cash equivalents, restricted cash, and marketable securities | ​ |  | 2,507,326 | ​ |  | 244,012
Deferred tax assets | ​ |  | 1,926 | ​ |  | 10,043
Other assets | ​ | ​ | 17,244 | ​ | ​ | 11,237
Assets held for sale | ​ |  | — | ​ |  | 495,213
Total assets | ​ | $ | 3,722,717 | ​ | $ | 1,819,512
Revenue from External Customers Attributed to Geographic Areas | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three Months Ended June 30, | ​ | ​ | Nine Months Ended June 30, | ​ | ​
​ |  | 2022 | ​ | 2021 | ​ | 2022 | ​ | 2021 | ​ | ​
Geographic Location: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
North America | ​ | $ | 88,557 | ​ | $ | 83,638 | ​ | $ | 285,283 | ​ | $ | 236,939 | ​ | ​
Europe | ​ | ​ | 25,042 | ​ | ​ | 27,009 | ​ | ​ | 75,863 | ​ | ​ | 82,412 | ​ | ​
China | ​ | ​ | 12,906 | ​ | ​ | 11,077 | ​ | ​ | 33,936 | ​ | ​ | 33,869 | ​ | ​
Asia Pacific/ Other | ​ | ​ | 6,230 | ​ | ​ | 7,363 | ​ | ​ | 22,849 | ​ | ​ | 23,544 | ​ | ​
Total | ​ | $ | 132,735 | ​ | $ | 129,087 | ​ | $ | 417,931 | ​ | $ | 376,764 | ​ | ​
​

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration